| [1] Lee Y, Ahn C, Han JJ, Choi H, Kim J, Yim J, Lee J, Provost P, Rådmark O, Kim S, Kim VN. The nuclear RNase III Drosha initiates microRNA processing. Nature, 2003, 425(6956): 415-419.[2] Bartel DP. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell, 2004, 116(2): 281-297.[3] Garzon R, Liu SJ, Fabbri M, Liu ZF, Heaphy CEA, Callegari E, Schwind S, Pang JX, Yu JH, Muthusamy N, Havelange V, Volinia S, Blum W, Rush LJ, Perrotti D, Andreeff M, Bloom-field CD, Byrd JC, Chan K, Wu LC, Croce CM, Marcucci G. MicroRNA-29b induces global DNA hypomethylation and tumor suppressor gene reexpression in acute myeloid leukemia by targeting directly DNMT3A and 3B and indirectly DNMT1. Blood, 2009, 113(25): 6411-6418.[4] Lewis BP, Burge CB, Bartel DP. Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell, 2005, 120(1): 15-20.[5] de Fougerolles A, Vornlocher HP, Maraganore J, Lieberman J. Interfering with disease: a progress report on siRNA-based therapeutics. Nat Rev Drug Discov, 2007, 6(6): 443-453.[6] Stevenson M. Therapeutic potential of RNA interference. N Engl J Med, 2004, 351(17): 1772-1777.[7] Kawasaki H, Taira K. Induction of DNA methylation and gene silencing by short interfering RNAs in human cells. Nature, 2004, 431(7005): 211-217.[8] Yekta S, Shih IH, Bartel DP. MicroRNA-directed cleavage of HOXB8 mRNA. Science, 2004, 304(5670): 594-596.[9] Song G, Zeng HZ, Li J, Xiao LF, He YZ, Tang YH, Li YR. miR-199a regulates the tumor suppressor mitogen-activated protein kinase kinase kinase 11 in gastric cancer. Biol Pharm Bull, 2010, 33(11): 1822-1827.[10] Zhang ZY, Li ZJ, Gao CP, Chen P, Chen JJ, Liu WZ, Xiao SD, Lu H. miR-21 plays a pivotal role in gastric cancer pathogenesis and progression. Lab Invest, 2008, 88(12): 1358-1366.[11] Tsujiura M, Ichikawa D, Komatsu S, Shiozaki A, Takeshita H, Kosuga T, Konishi H, Morimura R, Deguchi K, Fujiwara H, Okamoto K, Otsuji E. Circulating microRNAs in plasma of pa-tients with gastric cancers. Br J Cancer, 2010, 102(7): 1174-1179.[12] Sun QM, Gu HJ, Zeng Y, Xia Y, Wang Y, Jing Y, Yang L, Wang B. Hsa-mir-27a genetic variant contributes to gastric cancer suscep-tibility through affecting miR-27a and target gene expression. Cancer Sci, 2010, 101(10): 2241-2247.[13] Tsai KW, Hu LY, Wu CW, Li SC, Lai CH, Kao HW, Fang WL, Lin WC. Epigenetic regulation of miR-196b expression in gastric cancer. Genes Chromosomes Cancer, 2010, 49(11): 969-980.[14] Feng RH, Chen XH, Yu YY, Su LP, Yu BQ, Li JF, Cai Q, Yan M, Liu BY, Zhu ZG. miR-126 functions as a tumour suppressor in human gastric cancer. Cancer Lett, 2010, 298(1): 50-63.[15] Shinozaki A, Sakatani T, Ushiku T, Hino rR, Isogai M, Ishikawa S, Uozaki H, Takada K, Fukayama M. Downregulation of microRNA-200 in EBV-associated gastric carcinoma. Cancer Res, 2010, 70(11): 4719-4727.[16] Tsukamoto Y, Nakada C, Noguchi T, Tanigawa M, Nguyen LT, Uchida T, Hijiya N, Matsuura K, Fujioka T, Seto M, Moriyama M. MicroRNA-375 is downregulated in gastric carcinomas and regulates cell survival by targeting PDK1 and 14-3-3ζ. Cancer Res, 2010, 70(6): 2339-2349.[17] Ding L, Xu YJ, Zhang W, Deng YJ, Si MS, Du Y, Yao HM, Liu XY, Ke YH, Si JM, Zhou TH. MiR-375 frequently downregulated in gastric cancer inhibits cell proliferation by targeting JAK2. Cell Res, 2010, 20(7): 784-793.[18] Wada R, Akiyama Y, Hashimoto Y, Fukamachi H, Yuasa Y. miR-212 is downregulated and suppresses methyl-CpG-binding protein MeCP2 in human gastric cancer. Int J Cancer, 2010, 127(5): 1106-1114.[19] Suzuki H, Yamamoto E, Nojima M, Kai M, Yamano HO, Yoshi-kawa K, Kimura T, Kudo T, Harada E, Sugai T, Takamaru H, Ni-inuma T, Maruyama R, Yamamoto H, Toki |
